source
- Endpoints Weekly celebrates Neal Awards while previewing Sanofi, Lilly and RevMed updatesEndpoints Weekly released its latest edition on April 25, 2026, noting a celebratory tone after the publication earned three Neal Awards for B2B journalism excellence. The issue highlights several…
- European regulators recommend Sanofi's MS drug tolebrutinib for approval after US rejectionEuropean Medicines Agency officials issued a positive recommendation for tolebrutinib, an experimental multiple sclerosis therapy from Sanofi, after the U.S. FDA rejected the drug earlier this year…